Day One Biopharmaceuticals, INC. (DAWN) SEC Filings — 2025
11 SEC filings for Day One Biopharmaceuticals, INC. (DAWN) in 2025.
Filings
- Day One Biopharma Files 8-K — 8-K · Nov 24, 2025
- Day One Biopharmaceuticals Enters Material Definitive Agreement — 8-K · Nov 13, 2025
- DAWN's Q3 Loss Widens Amidst Plummeting License Revenue — 10-Q · Nov 4, 2025
- Day One Biopharma Reports Director Changes and Executive Compensation Updates — 8-K · Oct 10, 2025
- Day One Biopharma Posts No Revenue, $109.8M Net Loss in Q2 — 10-Q · Aug 5, 2025
- Day One Biopharma Files 8-K on Shareholder Vote Matters — 8-K · Jun 3, 2025
- Day One Bio Q1 2025 Update: R&D, Revenue Details — 10-Q · May 6, 2025
- Day One Biopharma Files Definitive Proxy Statement — DEF 14A · Apr 11, 2025
- Day One Bio files 10-K/A amendment — 10-K/A · Mar 6, 2025
- Day One Biopharmaceuticals, INC. 10-K Filing — 10-K · Feb 25, 2025
- Day One Biopharma Files 8-K — 8-K · Jan 13, 2025